Ke-Fei Dou

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Fu Wai Hospital · ORCID：0000-0003-0613-5857

发表论文 4 篇 · 总被引 11 次 · h-index 2

代表论文

• Benefits and Risks of Prolonged Duration Dual Antiplatelet Therapy (Clopidogrel and Aspirin) After Percutaneous Coronary Intervention in High-Risk Patients With Diabetes Mellitus (2020 · The American Journal of Cardiology · 被引 6)
• Effect of changes in the triglyceride-glucose index on atherogenic lipid profiles in coronary artery disease patients receiving lipid-lowering therapy: a prospective cohort study (2025 · Cardiovascular Diabetology · 被引 4)
• Liraglutide alleviates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by enhancing mitophagy mediated by the AMPK-Parkin signaling pathway (2025 · World Journal of Diabetes · 被引 1)
• Abstract 4365814: Impact of Lipoprotein(a) on Aortic Valve Replacement in Chinese Patients with Mild-to-Moderate Calcific Aortic Valve Stenosis (2025 · Circulation)